title: Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia.
abstract: OBJECTIVE
  To compare the efficacy of verapamil and diltiazem as slow infusions in terminating spontaneous supraventricular tachycardia (SVT) in the emergency department (ED).
  
  
  METHODS
  Patients of at least 10 years of age who presented to our ED with regular narrow complex tachycardia not converted with a vagal manoeuvre with an ECG diagnosis of SVT were included. Those who were haemodynamically unstable were excluded. Patients were randomized to undergo either verapamil infusion at a rate of 1 mg/min to a maximum of 20 mg or diltiazem infusion at a rate of 2.5 mg/min to a maximum of 50 mg.
  
  
  RESULTS
  Eighty-one patients were randomized to receive verapamil infusion and 80 were randomized to receive the diltiazem infusion. There is no difference in success rate between verapamil (98.8%) and diltiazem (96.3%) infusion. The dose of medication required to convert 25,50 and 75% of SVTs were 4.0,5.0 and 8.0 mg for the verapamil infusion and 10.0,12.5 and 17.5 mg for the diltiazem infusion. There was one complication in each group.
  
  
  CONCLUSIONS
  Calcium channel blockers infusions were safe and efficacious in terminating spontaneous SVT. There was no difference between the success rates of verapamil and diltiazem infusions.
authors.affiliation: Department of Emergency Medicine, Singapore General Hospital, Outram Road, Singapore 169608, Singapore.
authors.forename: S H
authors.initials: SH
authors.lastname: Lim
authors.forename: V
authors.initials: V
authors.lastname: Anantharaman
authors.forename: W S
authors.initials: WS
authors.lastname: Teo
mesh_terms: D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000627:therapeutic use; D004110:Diltiazem / Q000008:administration & dosage* / Q000627:therapeutic use; D004562:Electrocardiography; D004638:Emergency Treatment; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013617:Tachycardia, Supraventricular / Q000175:diagnosis / Q000188:drug therapy*; D014700:Verapamil / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem